Cholesterol ingredient of Comirnaty and its half life
Erika Whittome made this Official Information request to Ministry of Health
Response to this request is delayed. By law, Ministry of Health should normally have responded promptly and by (details and exceptions)
From: Erika Whittome
Dear Ministry of Health,
I note the Comirnaty product lists cholesterol as an ingredient in the "6.1 List of excipients"
https://www.medsafe.govt.nz/profs/Datash...
1. Would you please provide the all the pharmacokinetics of the cholesterol ingredient in Comirnaty?
I request the information on how this substance gets absorbed, distributed, metabolised in, and excreted from the body.
2. What is the excretion and half-life of this particular cholesterol ingredient in the Comirnaty injections from Pfizer/BioNTech?
Yours faithfully,
Erika Whittome
From: OIA Requests
Kia ora Erika
Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health on 1 October 2025. You requested:
1. Would you please provide the all the pharmacokinetics of the
cholesterol ingredient in Comirnaty?
I request the information on how this substance gets absorbed,
distributed, metabolised in, and excreted from the body.
2. What is the excretion and half-life of this particular cholesterol
ingredient in the Comirnaty injections from Pfizer/BioNTech?
The reference number for your request is H2025073480. As required under
the Act, the Ministry will endeavour to respond to your request no later
than 20 working days after the day your request was
received: [1]http://www.ombudsman.parliament.nz/
If you have any queries related to this request, please do not hesitate to
get in touch ([2][email address]).
Ngā mihi
OIA Services Team
[3]Ministry of Health information releases
show quoted sections
References
Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
From: OIA Requests
Kia ora Erika
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services Team
Ministry of Health | Manatū Hauora
M[1]inistry of Health information releases
show quoted sections
References
Visible links
1. https://www.health.govt.nz/about-ministr...
From: Erika Whittome
Dear OIA Requests,
You have e shared documents from Nga Kaitiaki Tuku Iho Medical Action Society Inc v Minister of Health
However, there is no information on the cholesterol in those documents .
Kindly share the requested information before I complain to the ombudsman
Yours sincerely,
Erika Whittome
From: OIA Requests
Kia ora Erika
As noted in your response, distribution studies of ingredients (including
cholesterol) are included in non-clinical studies (refer to document 12).
Further non-clinical data relating to Comirnaty is withheld under
9(2)(b)(ii) of the Act.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [email address] or by calling 0800 802
602.
Ngā mihi
OIA Services Team
Ministry of Health | Manatū Hauora
M[1]inistry of Health information releases
--------------------------------------------------------------------------
From: Erika Whittome <[FOI #32433 email]>
Sent: Thursday, 30 October 2025 07:09
To: OIA Requests <[email address]>
Subject: Re: Response to your request for information, ref: H2025073480
CRM:0001499
Dear OIA Requests,
You have e shared documents from Nga Kaitiaki Tuku Iho Medical Action
Society Inc v Minister of Health
However, there is no information on the cholesterol in those documents .
Kindly share the requested information before I complain to the ombudsman
Yours sincerely,
Erika Whittome
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence (note: this contains the same information already available above).

